Recall Radar
All recallsMedicine & devices

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355,…

Crystallization; identified as Buprenorphine free base

Class II Medicine & devices FDA June 24, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Par Health USA, LLC — Rochester, MI
Severity
Class II — moderate
Reported
June 24, 2026
Quantity
46,334 units
Recall number
D-0596-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA.

Other medicine & devices recalls

See every current recall on the live dashboard →